ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, reported strong sales in Q1, reaching 21.1 MSEK, 9% higher than the first quarter last year. The company reports positive feedback from user tests within digital pathology and continues to proceed with product development for this fast-growing market.
March 11st, 2019 – An article about ContextVision has been published in the Norwegian business newspaper Finansavisen (in Norwegian only). Please find a link here. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43
Today ContextVision held a company presentation at Danske Bank's Small & Mid Cap Seminar in Stockholm, Sweden.CEO Anita Tollstadius gave an update of the company's development and shared the company's future direction.
STOCKHOLM – February 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, is closing in on a commercial product within digital pathology with a planned launch in 2019. Tests prove that ContextVision’s algorithms perform as well as pathologists and have also helped identify suspicious cancer areas that are […]
ContextVision to showcase Altumira(TM), AI-powered image enhancement for digital radiography at ECR 2019
With deep learning technology integrated, Altumira is specially designed to meet the demanding needs of digital radiography for both dynamic and static X-ray. At ECR, the full suite of industry-leading image enhancement products for ultrasound will be showcased. ContextVision's products deliver unsurpassed image quality for all types of ultrasound systems from handheld devices to the most advanced 3D/4D applications.
With the integration of deep learning technology, ContextVision takes digital radiography to new levels with its latest image enhancement platform, Altumira(TM).